CNTX
Price
$1.13
Change
-$0.02 (-1.74%)
Updated
Dec 26 closing price
Capitalization
105.66M
88 days until earnings call
Intraday BUY SELL Signals
PRQR
Price
$2.17
Change
-$0.00 (-0.00%)
Updated
Dec 26, 04:59 PM (EDT)
Capitalization
228.6M
54 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CNTX vs PRQR

Header iconCNTX vs PRQR Comparison
Open Charts CNTX vs PRQRBanner chart's image
Context Therapeutics
Price$1.13
Change-$0.02 (-1.74%)
Volume$109.31K
Capitalization105.66M
ProQR Therapeutics
Price$2.17
Change-$0.00 (-0.00%)
Volume$4.28K
Capitalization228.6M
CNTX vs PRQR Comparison Chart in %
CNTX
Daily Signal:
Gain/Loss:
PRQR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CNTX vs. PRQR commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTX is a Buy and PRQR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 27, 2025
Stock price -- (CNTX: $1.15 vs. PRQR: $2.17)
Brand notoriety: CNTX and PRQR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTX: 23% vs. PRQR: 29%
Market capitalization -- CNTX: $105.66M vs. PRQR: $228.6M
CNTX [@Biotechnology] is valued at $105.66M. PRQR’s [@Biotechnology] market capitalization is $228.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTX’s FA Score shows that 1 FA rating(s) are green whilePRQR’s FA Score has 1 green FA rating(s).

  • CNTX’s FA Score: 1 green, 4 red.
  • PRQR’s FA Score: 1 green, 4 red.
According to our system of comparison, CNTX is a better buy in the long-term than PRQR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTX’s TA Score shows that 3 TA indicator(s) are bullish while PRQR’s TA Score has 4 bullish TA indicator(s).

  • CNTX’s TA Score: 3 bullish, 7 bearish.
  • PRQR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PRQR is a better buy in the short-term than CNTX.

Price Growth

CNTX (@Biotechnology) experienced а +2.68% price change this week, while PRQR (@Biotechnology) price change was +1.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.37%. For the same industry, the average monthly price growth was +0.28%, and the average quarterly price growth was +55.43%.

Reported Earning Dates

CNTX is expected to report earnings on Mar 25, 2026.

PRQR is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (+0.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRQR($229M) has a higher market cap than CNTX($106M). CNTX YTD gains are higher at: 9.524 vs. PRQR (-18.113). CNTX has higher annual earnings (EBITDA): -30.19M vs. PRQR (-38.15M). PRQR has more cash in the bank: 107M vs. CNTX (76.9M). CNTX has less debt than PRQR: CNTX (140K) vs PRQR (16.5M). PRQR has higher revenues than CNTX: PRQR (15.5M) vs CNTX (0).
CNTXPRQRCNTX / PRQR
Capitalization106M229M46%
EBITDA-30.19M-38.15M79%
Gain YTD9.524-18.113-53%
P/E RatioN/AN/A-
Revenue015.5M-
Total Cash76.9M107M72%
Total Debt140K16.5M1%
FUNDAMENTALS RATINGS
PRQR: Fundamental Ratings
PRQR
OUTLOOK RATING
1..100
87
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CNTXPRQR
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 8 days ago
88%
Bullish Trend 18 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 9 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
CNTX
Daily Signal:
Gain/Loss:
PRQR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UUUFF0.110.01
+5.12%
VANGUARD MNG CORP.
HWDJY44.50N/A
N/A
Howden Joinery Group Plc
OSGCF13.66N/A
N/A
Osg Corp. Co. Ltd.
NOBH30.25-0.10
-0.33%
Nobility Homes, Inc.
DKILY12.91-0.07
-0.54%
Daikin Industries Ltd.

CNTX and

Correlation & Price change

A.I.dvisor tells us that CNTX and IPSC have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNTX and IPSC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTX
1D Price
Change %
CNTX100%
+3.60%
IPSC - CNTX
32%
Poorly correlated
+6.19%
ORKA - CNTX
32%
Poorly correlated
+1.29%
PRQR - CNTX
29%
Poorly correlated
-1.81%
PROK - CNTX
29%
Poorly correlated
+2.80%
CRBP - CNTX
29%
Poorly correlated
+2.93%
More

PRQR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRQR has been loosely correlated with BEAM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PRQR jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRQR
1D Price
Change %
PRQR100%
-1.81%
BEAM - PRQR
49%
Loosely correlated
+1.33%
RGNX - PRQR
48%
Loosely correlated
+0.77%
ETHZ - PRQR
44%
Loosely correlated
-4.11%
DNLI - PRQR
44%
Loosely correlated
+1.07%
SYRE - PRQR
43%
Loosely correlated
-0.54%
More